12P: Camrelizumab plus chemotherapy (Cam-chemo) as first-line (1L) therapy for advanced squamous non-small cell lung cancer (sqNSCLC): 5y update from the phase III CameL-sq trial

作者：Chengzhi Zhou, Shengsheng Ren, Junru Chen, Xingxiang Xu, Ying Cheng, Gang Chen, Yueyin Pan, Y. Fang, Qi Wang, Yunchao Huang, Wu Yao, Rui Wang, Xiang Li, W. Zhang, Ying Zhang, Shengshou Hu, R-H. Guo, Dong Wang, Zhoufeng Wang, Xia Lu · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/s1556-0864(25)00207-2 · 被引用次数：3 · 研究领域：Cancer Immunotherapy and Biomarkers、Lung Cancer Treatments and Mutations、Lung Cancer Research Studies